Cellebrite DI (CLBT) Net Cash Flow (2020 - 2025)

Cellebrite DI (CLBT) has reported Net Cash Flow for 6 consecutive years, with -$157.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Net Cash Flow fell 376.59% year-over-year to -$157.0 million; the TTM figure through Dec 2025 stood at -$69.7 million (down 2179.81% YoY), while the FY2025 annual figure was -$69.7 million, down 2179.81% from the prior year.
• Net Cash Flow came in at -$157.0 million for Q4 2025 at Cellebrite DI, down from $102.3 million in the prior quarter.
• The five-year high for Net Cash Flow was $102.3 million in Q3 2025, with the low at -$157.0 million in Q4 2025.
• Average Net Cash Flow over 5 years is $3.3 million, with a median of $11.3 million recorded in 2023.
• Across the five-year window, Net Cash Flow tumbled 696.71% in 2024 and soared 663.86% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $36.2 million in 2021, then surged by 107.84% to $75.2 million in 2022, then slumped by 31.46% to $51.5 million in 2023, then rose by 10.15% to $56.7 million in 2024, then tumbled by 376.59% to -$157.0 million in 2025.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$157.0 million, $102.3 million, and $87.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.